These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 30817302

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
    Cavarzere P, Camilot M, Teofoli F, Tatò L.
    Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Neonatal screening for congenital adrenal hyperplasia: experience and results in Argentina.
    Gruñieiro-Papendieck L, Chiesa A, Mendez V, Prieto L.
    J Pediatr Endocrinol Metab; 2008 Jan; 21(1):73-8. PubMed ID: 18404975
    [Abstract] [Full Text] [Related]

  • 27. Newborn screening for congenital adrenal hyperplasia in Sapporo City: sixteen years experience.
    Mikami A, Fukushi M, Oda H, Fujita K, Fujieda K.
    Southeast Asian J Trop Med Public Health; 1999 Jan; 30 Suppl 2():100-2. PubMed ID: 11400741
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Nimkarn S, Gangishetti PK, Yau M, New MI.
    ; 1993 Jan. PubMed ID: 20301350
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia.
    Tieh PY, Yee JK, Hicks RA, Mao CS, Lee WN.
    J Perinatol; 2017 Mar; 37(3):283-287. PubMed ID: 27929529
    [Abstract] [Full Text] [Related]

  • 35. Characteristics of Patients with Classic Congenital Adrenal Hyperplasia Missed on the Newborn Screen.
    Saroufim R, Nebesio TD, Eugster EA.
    Horm Res Paediatr; 2024 Mar; 97(5):470-476. PubMed ID: 37992692
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
    Hayashi GY, Carvalho DF, de Miranda MC, Faure C, Vallejos C, Brito VN, Rodrigues AS, Madureira G, Mendonca BB, Bachega TA.
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.